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In search of viable strategies to identify selective inhibitors of protein kinases, we have designed a binding assay to probe the
interactions of human phosphoinositide-dependent protein kinase-1 (PDK1) with potential ligands. Our protocol is based on
ﬂuorescence resonance energy transfer (FRET) between semiconductor quantum dots (QDs) and organic dyes. Speciﬁcally, we
have expressed and puriﬁed the catalytic kinase domain of PDK1 with an N-terminal histidine tag [His6-PDK1(ΔPH)]. We have
conjugated this construct to CdSe-ZnS core-shell QDs coated with dihydrolipoic acid (DHLA) and tested the response of the
resultingassemblytoamoleculardyadincorporatinganATPligandandaBODIPYchromophore.Thesupramolecularassociation
oftheBODIPY-ATPdyadwiththeHis6-PDK1(ΔPH)-QDassemblyencouragesthetransferofenergyfromtheQDstotheBODIPY
dyes upon excitation. The addition of ATP results in the displacement of BODIPY-ATP from the binding domain of the His6-
PDK1(ΔPH) conjugated to the nanoparticles. The competitive binding, however, does not prevent the energy transfer process.
A control experiment with QDs, lacking the His6-PDK1(ΔPH), indicates that the BODIPY-ATP dyad adsorbs nonspeciﬁcally on
the surface of the nanoparticles, promoting the transfer of energy from the CdSe core to the adsorbed BODIPY dyes. Thus, the
implementation of FRET-based assays to probe the binding domain of PDK1 with luminescent QDs requires the identiﬁcation of
energy acceptors unable to interact nonspeciﬁcally with the surface of the nanoparticles.
Copyright © 2007 Ibrahim Yildiz et al. This isan open access article distributed under theCreative CommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The outstanding photophysical properties of semiconduc-
tor quantum dots (QDs) have encouraged the development
of binding assays, based on ﬂuorescence resonance energy
transfer(FRET),forthedetectionofadiversityofbiorelevant
analytes [1–5]. Some of these sensing protocols are aimed
at the investigation of protein-ligand interactions relying on
FRET in QD-protein-dye assemblies. For example, the mal-
tose binding protein (MBP) was expressed with a C-terminal
oligohistidine segment to promote its adsorption on the sur-
face of CdSe-ZnS core-shell QDs coated with dihydrolipoic
acid (DHLA) [6, 7]. By conjugating the dark quencher QSY9
to β-cyclodextrin, it was shown that titration of the solu-
tion containing QD-bound MBP with β-cyclodextrin-QSY9
eﬀectively quenched the nanoparticle luminescence. Such a
system was further demonstrated to function as a proto-
type nanosensor. In fact, the QD luminescence could be re-
stored on subsequent titration with maltose, which compet-
itively displaced β-cyclodextrin-QSY9 from the sugar bind-
ing pocket. In principle, a similar strategy could be invoked
for the detection of compounds that competitively displace
an enzyme-bound dye-labeled substrate for use in high-
throughput drug screening assays.
Discovering potent and selective inhibitors of individual
members of the protein kinase superfamily has proved to be
a long and arduous task. Whereas a large number of high
aﬃnity inhibitors have been identiﬁed, the majority of such
compoundsexhibitbroadspeciﬁcitysincetheytypicallybind
in the ATP-binding cleft shared among all kinase enzymes
[8–10]. The matter is further complicated by the fact that
the protein kinase superfamily is the largest enzyme family
with an estimated 518 members in the human genome [11].
The broad speciﬁcity kinase inhibitors are commonly identi-
ﬁedinhigh-throughputenzymaticscreeningassays,whereby
kinase activity is monitored by phosphorylation-induced2 Journal of Biomedicine and Biotechnology
ﬂuorescence changes in model peptide substrates. Such en-
zymatic assays demand active forms of the kinase, which re-
quire one or more critical residues to be phosphorylated. In-
spection of X-ray structures available for the catalytic do-
mains of diﬀerent kinases in their phosphorylated and ac-
tive forms shows highly homologous structures, especially
in the ATP-binding cleft [12]. However, known structures
of catalytic kinase domains in their unphosphorylated and
inactive forms reveal greater divergence of conformational
space, which may better accommodate selective binding of
compounds that stabilize inactive conformations [12]. Thus,
wesoughttodeterminewhethercompetitivedisplacementof
dye-labeled ATP from protein kinase-QD assemblies could
be used as a sensitive assay for the detection of compounds
that bind either active or inactive forms of kinases.
Thehumanphosphoinositide-dependent proteinkinase-
1 (PDK1) is particularly well suited to initiate develop-
ment of QD-mediated competitive binding assays. PDK1 is
a member of the AGC subfamily of serine-threonine pro-
tein kinases and is comprised of an N-terminal catalytic ki-
nase domain and a C-terminal pleckstrin homology (PH)
domain [13]. Baculovirus-mediated expression in Sf9 in-
sect cells and aﬃnity puriﬁcation of the recombinant cat-
alytic domain construct of PDK1 (residues 51–359) with an
N-terminal His6 tag is well established, and this construct
[His6-PDK1(ΔPH)] exhibits high solution stability [14–16].
His6-PDK1(ΔPH) catalyzes autophosphorylation of Ser-241
located in its activation or T-loop, which is the only post-
translational modiﬁcation required for its kinase function
[14–16]. Most interestingly, Ser-241 monophosphorylated
His6-PDK1(ΔPH) remains relatively inactive, and it is ulti-
mately activated by allosteric interaction with a phosphory-
lated hydrophobic motif (HM) at the C-terminus of its pro-
tein substrate [14–16]. The phosphorylated HM has been
termed the “PDK1 interacting fragment” or PIF, and it binds
to the PIF pocket on the N-lobe of the PDK1 kinase domain
[17–20]. Kinetic studies indicate that His6-PDK1(ΔPH) ap-
proximates a Rapid Equilibrium Random Bi Bi System so
that it readily forms a high-aﬃnity complex with ATP in
the absence of protein substrate [15], as exempliﬁed by the
X-ray structure reported for the binary enzyme-nucleotide
complex [14]. In this article, we report the ability of His6-
PDK1(ΔPH)toadsorbonthesurfaceofCdSe-ZnScore-shell
QDs coated with DHLA and the interactions of the resulting
assemblies with a compound incorporating an ATP ligand
and a BODIPY chromophore within its molecular skeleton.
2. MATERIALS AND METHODS
CdSe-ZnS core-shell QDs were prepared following literature
procedures [21, 22] and then coated with DHLA according
to an established protocol [23]. His6-PDK1(ΔPH) was ex-
pressed using the Bac-to-Bac Baculovirus Expression System
(Invitrogen, Inc., Carlsbad, Calif, USA) and puriﬁed as re-
ported earlier [24]. BODIPY TR adenosine 5 -triphosphate
(BODIPY-ATP) was purchased from commercial sources
(Invitrogen, Inc.). Visible absorption spectra were recorded
with a Varian Cary 100 Bio spectrometer using quartz cells
with a path length of 0.5cm. Emission spectra were recorded
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Figure 1: Emission spectra of CdSe-ZnS core-shell QDs (0.1μMi n
boratebuﬀer,pH =7.4,T =20◦C,λEX =442nm)coatedwithDHLA
in the absence (a) and presence of 0.5 (b), 1.0 (c), 2.0 (d), 5.0 (e),
and 10.0 (f) μMo fH i s 6-PDK1(ΔPH).
with a Varian Cary Eclipse spectrometer in aerated solutions
and are uncorrected with the exception of those shown in
Figure 8.
3. RESULTS AND DISCUSSION
The emission spectrum (a in Figure 1) of CdSe-ZnS core-
shell QDs coated with DHLA in borate buﬀer (pH = 7.4)
shows an intense band centered at 600nm with a quantum
yield of 0.2. The addition of His6-PDK1(ΔPH) to this dis-
persion aﬀects the emissive behavior of the nanoparticles.
Speciﬁcally, the luminescence increases with the concentra-
tionofHis6-PDK1(ΔPH)(a–finFigure 1)inagr eementwith
the adsorption of the protein on the surface of the QDs.
Indeed, literature reports [6] demonstrate that the coating
of CdSe-ZnS core-shell QDs with histidine-tagged proteins
leads to a luminescence enhancement, as a result of the sig-
niﬁcant change in the local environment around the emis-
sive inorganic particles. In particular, the plot (see Figure 2)
of the emission intensity of our QDs at 600nm against the
relative concentration of His6-PDK1(ΔPH) shows that satu-
ration is reached at a protein/QD ratio of ca. 30. Under these
conditions, the luminescence quantum yield of the nanopar-
ticles is 0.4.
Theabsorptionspectrum(ainFigure 3)ofBODIPY -A TP
shows an intense band for the ﬂuorescent component of this
dyad in the visible region. This absorption is positioned in
the same range of wavelengths where our QDs emit (b in
Figure 3) with an overlap integral of 5.3·10−13 M−1cm3, sug-
gesting that the BODIPY dye can accept the excitation en-
ergy of these nanoparticles. The overlap integral (J)w a sc a l -
culated from the emission intensity (I) of the quantum dots,
the molar extinction coeﬃcient (ε) of the BODIPY dye and
the wavelength (λ) using
J =
 ∞
0 Iελ4dλ
 ∞
0 Idλ
. (1)Ibrahim Yildiz et al. 3
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Figure 2:Emissionintensityat600nmofCdSe-ZnScore-shellQDs
(0.1μMi nb o r a t eb u ﬀer, pH = 7.4, T = 20◦C, λEX = 442nm) coated
with DHLA against the ratio between the concentration of His6-
PDK1(ΔPH) and that of the QDs.
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Figure 3: Absorption spectrum (a) of BODIPY-ATP (30μM) and
emission spectrum (b) of CdSe-ZnS core-shell QDs (0.1μM) and
His6-PDK1(ΔPH) in borate buﬀer (pH = 7.4, T = 20◦C, λEX =
442nm).
Thus, the supramolecular association of the ATP fragment
of the dyad with the His6-PDK1(ΔPH) coating of the QDs
can be exploited to bring the BODIPY ﬂuorophore in close
proximity to the nanoparticles and encourage the transfer of
energy from the emissive CdSe core to the organic dye (a
in Figure 4). Indeed, the addition of increasing amounts of
BODIPY-ATP to the His6-PDK1(ΔPH)-QD conjugate alters
signiﬁcantly the emission spectrum (a–g in Figure 5). In par-
ticular, the emission band of the QDs at 600nm fades with
an increase in the concentration of BODIPY-ATP. Concomi-
tantly, a second band for the BODIPY ﬂuorophore grows at
624nm in agreement with the expected transfer of energy
from the nanoparticles to the organic dye upon excitation.
In principle, the addition of a ligand able to displace
BODIPY-ATP from the complementary recognition site of
the His6-PDK1(ΔPH)-QD conjugate should result in the
physicalseparationofthenanoparticledonorfromtheBOD-
His6-PDK1 (ΔPH)
+ QD
(a) (b)
(c) (d)
Energy
transfer BODIPY
ATP
ATP
Energy
transfer
Energy
transfer
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Figure 4: The supramolecular association of BODIPY-ATP with
His6-PDK1(ΔPH)-QD encourages the transfer of energy from
QD to BODIPY upon excitation (a). ATP displaces BODIPY-ATP
from the recognition site of His6-PDK1(ΔPH)-QD and is ex-
pected to prevent energy transfer (b). The nonspeciﬁc adsorption
of BODIPY-ATP on the surface of QD, however, can also encour-
age energy transfer (c). Under these conditions, the displacement of
BODIPY-ATP by ATP is not suﬃcient to prevent energy transfer.
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Figure 5: Emission spectra of a dispersion of CdSe-ZnS core-shell
QDs (0.1μM) and His6-PDK1(ΔPH) (10μM) in borate buﬀer (pH
=7.4,T =20◦C,λEX =442nm)intheabsence(a)andpresenceof1.0
(b), 3.0 (c), 5.0 (d), 10.0 (e), 20.0 (f), and 30.0 (g) μMo fB O D I P Y -
ATP.
IPYacceptorand,therefore,suppresstheenergytransferpro-
cesses(binFigure 4).Consistently,theadditionofincreasing
amountsofATPtoasolutionofthecomplexformedbetween
BODIPY-ATP and His6-PDK1(ΔPH)-QD causes a decrease
in emission intensity with a concomitant hypsochromic shift
(a–f in Figure 6). Instead, the titration of a dispersion of the
QDs (0.1μM) with ATP (0–30μM) has no inﬂuence on their
emission spectrum. The deconvolution of the ﬁnal spectrum
(a in Figure 7) shows the observed emission to be the sum of
two distinct bands (b and c in Figure 7). One of them (b in
Figure 7) is centered at 600nm, corresponds to the emission4 Journal of Biomedicine and Biotechnology
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Figure 6: Emission spectra of a mixture of CdSe-ZnS core-
shell QDs (0.1μM), His6-PDK1(ΔPH) (10μM) and BODIPY-ATP
(10μM) in borate buﬀer (pH = 7.4, T = 20◦C, λEX = 442nm) in the
absence (a) and presence of 1 (b), 3 (c), 11 (d), 31 (e), and 301 (f)
μMo fA T P .
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Figure 7: Emission spectra of a mixture of CdSe-ZnS core-shell
QDs (0.1μM), His6-PDK1(ΔPH) (10μM), BODIPY-ATP (10μM)
and ATP (301μM) (a) CdSe-ZnS core-shell QDs (0.1μM) (d) and
BODIPY-ATP (10μM) (e) in borate buﬀer (pH = 7.4, T = 20◦C, λEX
= 442nm). Deconvolution (b and c) of trace a.
of the QDs, and its intensity is signiﬁcantly smaller than that
recorded for a dispersion of the QDs alone (d in Figure 7)
under otherwise identical conditions. The other band (c in
Figure 7) is centered at 624nm, corresponds to the emis-
sion of the BODIPY dyes, and its intensity is greater than
that recorded for BODIPY-ATP alone (e in Figure 7)u n d e r
otherwise identical conditions. Thus, the QDs recover their
luminescence only in part, even after the addition of a rel-
atively large amount of ATP, and still sensitize the emission
of the BODIPY dyes under these conditions. These obser-
vations suggest that a fraction of the BODIPY-ATP conju-
gates remains associated with the QDs even in the presence
of an excess of ATP (c and d in Figure 4). In agreement with
this interpretation, the addition of increasing amounts of
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Figure 8: Emission spectra of CdSe-ZnS core-shell QDs (0.1μMi n
borate buﬀer, pH = 7.4, T = 20◦C, λEX = 442nm) in the absence (a)
andpresenceof1.0(b),3.0(c),5.0(d),and10.0(e)μMofBODIPY -
ATP.
BODIPY-ATP to a dispersion of QDs leads to the disappear-
ance of the nanoparticle emission at 600nm with the con-
comitant appearance of the BODIPY emission at 624nm (a–
ei nFigure 8). Hence, the BODIPY-ATP can accept the ex-
citation energy of the QDs despite the absence of the His6-
PDK1(ΔPH) coating around the nanoparticles. These results
suggest that the BODIPY-ATP conjugate can adsorb non-
speciﬁcally on the QDs, presumably, as a result of interac-
tions between the chromophoric component and the surface
of the nanoparticles.
4. CONCLUSIONS
The incubation of CdSe-ZnS core-shell QDs, coated with
DHLA, and His6-PDK1(ΔPH) in borate buﬀer (pH = 7.4)
leads to the adsorption of proteins on the surface of the
nanoparticles with a concomitant luminescence enhance-
ment. The dependence of the emission intensity on the pro-
tein concentration suggests that an average of ca. 30 proteins
adsorb on each QD. The exposure of the His6-PDK1(ΔPH)-
QD conjugate to a BODIPY-ATP dyad brings the inor-
ganic nanoparticle in close proximity to the BODIPY chro-
mophore, encouraging the transfer of energy from the for-
mer to the latter. Consistently, the emission band of the QDs
fades, as the concentration of BODIPY-ATP increases, with
the concomitant growth of an emission band for organic
dye. The competitive binding of ATP, however, restores the
nanoparticle luminescence only in part. Indeed, control ex-
periments show the occurrence of energy transfer between
QDs lacking the His6-PDK1(ΔPH) shell and BODIPY-ATP.
These observations suggest that the organic chromophore
adsorbs nonspeciﬁcally on the surface of the nanoparticles.
Thus, the development of binding assays for PDK1 based on
QDs and FRET demands the identiﬁcation of strategies to
prevent the direct adsorption of the energy acceptor on the
surface of the nanoparticle donor.Ibrahim Yildiz et al. 5
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